Impact of response shift on longitudinal quality-of-life assessment in cancer clinical trials

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 11, Issue 5, 2011, Pages 549-559

  Hamidou, Zeinab ^a   Dabakuyo, Tienhan Sandrine ^a   Bonnetain, Franck ^a  

^a Georges Franois Leclerc Cancer Center   (France)

Author keywords

cancer clinical trials; health related quality of life; longitudinal analysis; response shift

Indexed keywords

BREAST CANCER; CALIBRATION; CANCER PATIENT; CANCER RESEARCH; CHEMORADIOTHERAPY; CLINICAL TRIAL (TOPIC); COLON CANCER; ESOPHAGUS CANCER; FATIGUE; HEALTH STATUS; HODGKIN DISEASE; HUMAN; LONGITUDINAL STUDY; LUNG CANCER; MULTIPLE MYELOMA; OUTCOME ASSESSMENT; PROSTATE CANCER; PSYCHOSOCIAL CARE; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RECALL BIAS; REVIEW; SCHEDULE FOR THE EVALUATION OF INDIVIDUAL QUALITY OF LIFE; SCORING SYSTEM;

CLINICAL TRIALS AS TOPIC; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; NEOPLASMS; QUALITY OF LIFE;

EID: 80053541107     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.11.57     Document Type: Review

References (64)

1. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J. Clin. Epidemiol. 56(5), 395-407 (2003). (Pubitemid 36694091)
2. Ubel PA, Peeters Y, Smith D. Abandoning the language of "response shift": a plea for conceptual clarity in distinguishing scale recalibration from true changes in quality of life. Qual. Life Res. 19(4), 465-471 (2010).
3. Sprangers MA, Schwartz CE. Integrating response shift into health related quality of life research: a theoretical model. Soc. Sci. Med. 48, 1507-1515 (1999). (Pubitemid 29254110)
4. Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health related quality of life research. Soc. Sci. Med. 48, 1531-1548 (1999). (Pubitemid 29254112)
5. Gibbons FX. Social comparison as a mediator of response shift. Soc. Sci. Med. 48, 1517-1530 (1999). (Pubitemid 29254111)
6. Wilson IB. Clinical understanding and clinical implications of response shift. Soc. Sci. Med. 48, 1577-1588 (1999). (Pubitemid 29254115)
7. Schwartz C, Bode R, Repucci N, Becker J, Sprangers M, Fayers P. The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual. Life Res. 15, 1533-1550 (2006). (Pubitemid 44736786)
8. Osborne RH, Hawkins M, Sprangers MA. Change of perspective: a measurable and desired outcome of chronic disease self-management intervention programs that violates the premise of preintervention/postintervention assessment. Arthritis Rheum. 55(3), 458-465 (2006). (Pubitemid 43887032)
9. Constitution of the World Health Organisation. World Health Organisation, Geneva, Switzerland (1946).
10. Gill TM, Feinstein AR. A critical appraisal of the quality-of-life measurements. JAMA 272, 619-626 (1994).
11. Kaplan RM, Bush JW. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychology 1, 61-80 (1982).
12. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N. Engl. J. Med. 334(13), 835-840 (1996). (Pubitemid 26099607)
13. Karnofsky D, Burchenal J. The clinical evaluation of chemotherapeutic agents. In: Evaluation of Chemotherapeutic Agents. Maclead C (Ed.). Columbia University Press, NY, USA, 191-205 (1949).
14. Johnson JR, Temple R. Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat. Rep. 69(10), 1155-1159 (1985).
15. Gotay CC, Moore TD. Assessing quality of life in head and neck cancer. Qual. Life Res. 1(1), 5-17 (1992).
16. Carr AJ, Gibson B, Robinson PG. Is quality of life determined by expectations or experience? BMJ 322, 1240-1243 (2001). (Pubitemid 32453083)
17. Allison PJ, Locker D, Feine JS. Quality of life: a dynamic construct. Soc. Sci. Med. 45(2), 221-230 (1997). (Pubitemid 27270372)
18. Calman KC. Quality of life in cancer patients-an hypothesis. J. Med. Ethics 10(3), 124-127 (1984).
19. Diener E. Subjective well-being. Psychol. Bull. 95(3), 542-575 (1984).
20. Englert JS, Ahrens B, Gebhardt R et al. Implications of the concepts "coping" and "quality of life" for criteria of course and outcome. Pharmacopsychiatry 27(Suppl. 1), 34-36 (1994). (Pubitemid 24260113)
21. Howard GS, Ralph KM, Gulanick NA, Maxwell SE, Nance SW, Gerber SK. Internal invalidity in pre-test-posttest self-report evaluations and a re-evaluation of retrospective pre-tests. Appl. Psychol. Meas. 3, 1-23 (1979).
22. Howard GS, Dailey PR, Gulanick NA. The feasibility of informed pre-tests in attenuating response-shift bias. Appl. Psychol. Meas. 3, 481-494 (1979).
23. Howard GS, Millham J, Slaten S, O'Donnell L. Influence of subject response style effects on retrospective measures. Appl. Psychol. Meas. 5, 89-100 (1981).
24. Howard GS, Schmeck RR, Bray JH. Internal invalidity in studies employing self-report instruments. A suggested remedy. J. Ed. Meas. 16, 129-135 (1979).
25. Howard GS, Dailey PR. Response shift bias: a source of contamination of self-report measures. Appl. Psychol. Meas. 64, 144-150 (1979).
26. Golembiewski RT, Billingsley K, Yeager S. Measuring change and persistence in human affairs: types of change generated by OLD designs. JAB 12, 133-157 (1976).
27. Barclay-Goddard R, Epstein JD, Mayo NE. Response shift: a brief overview and proposed research priorities. Qual. Life Res. 18(3), 335-346 (2009).
28. Rapkin BD, Schwartz CE. Toward a theoretical model of quality-of-life appraisal: implications of findings from studies of response shift. Health Qual. Life Outcomes 2, 14 (2004).
29. Ahmed S, Mayo NE, Wood-Dauphinee S, Hanley JA, Cohen SR. Response shift influenced estimates of change in health-related quality of life poststroke. J. Clin. Epidemiol. 57(6), 561-570 (2004). (Pubitemid 38891493)
30. Razmjou H, Yee A, Ford M, Finkelstein JA. Response shift in outcome assessment in patients undergoing total knee arthroplasty. J. Bone Joint Surg. Am. 88(12), 2590-2595 (2006). (Pubitemid 44901945)
31. Ring L, Höfer S, Heuston F, Harris D, O'Boyle CA. Response shift masks the treatment impact on patient reported outcomes (PROs): the example of individual quality of life in edentulous patients. Health Qual. Life Outcomes 3, 55 (2005).
32. Bernhard J, Hürny C, Maibach R, Herrmann R, Laffer U. Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK). Ann. Oncol. 10(7), 775-782 (1999). (Pubitemid 29367993)
33. Bonnetain F, Bouch O, Michel P et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter Phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann. Oncol. 17(5), 827-834 (2006).
34. Sprangers MA. Disregarding clinical trial-based patient-reported outcomes is unwarranted: five advances to substantiate the scientific stringency of quality-of-life measurement. Acta Oncol. 49(2), 155-163 (2010).
35. Schwartz CE, Sprangers MA. Guidelines for improving the stringency of response shift research using the thentest. Qual. Life Res. 19(4), 455-464 (2010).
36. Nolte S, Elsworth GR, Sinclair AJ, Osborne RH. Tests of measurement invariance failed to support the application of the 'then-test'. J. Clin. Epidemiol. 62(11), 1173-1180 (2009).
37. McPhail S, Haines T. Response shift, recall bias and their effect on measuring change in health-related quality of life amongst older hospital patients. Health Qual. Life Outcomes 8, 65 (2010).
38. Visser MR, Smets EM, Sprangers MA, de Haes HJ. How response shift may affect the measurement of change in fatigue. J. Pain Symptom Manage. 20, 12-18 (2000). (Pubitemid 30628577)
39. Terborg JR, Maxwell SE, Howard GS. On the measurement and control of b change: problems with the Bedeian, Armenakis, and Gibson technique. Academy of Management 7, 292-295 (1982).
40. Terborg JR, Maxwell SE, Howard GS. Evaluating planned organizational change: a method for assessing a, b and g change. Academy of Management 5, 109-121 (1980).
41. Schmitt N, Pulakos E, Lieblein A. Comparison of three techniques to assess group-level b and g change. App. Psychol. Meas. 8, 249-260 (1984).
42. Powell C. Quality of life measurement. J. Med. Ethics 12, 222-223 (1987).
43. Visser MR, Oort FJ, Sprangers MA. Methods to detect response shift in quality of life data: a convergent validity study. Qual. Life Res. 14(3), 629-639 (2005). (Pubitemid 40576851)
44. Bernheim JL, Buyse M. The Anamnestic Comparative Self-Assessment for measuring the subjective quality of life of cancer patients. J. Psychosocial Oncol. 1, 25-38 (1983). (Pubitemid 14009519)
45. Bonnetain F, Conroy T, Velten M et al. Impact of response shift (RS) in longitudinal post-operative quality of life (QoL) analysis among breast cancer (BC) patients: a randomized multicenter cohort study. Presented at: 17th Annual Conference of the International Society for Quality of Life Research. London, UK, 27-30 October 2010.
46. O'Boyle CA, McGee H, Hickey A, O'Malley K, Joyce CR. Individual quality of life in patients undergoing hip replacement. Lancet 339(8801), 1088-1091 (1992).
47. Hickey AM, Bury G, O'Boyle CA, Bradley F, O'Kelly FD, Shannon W. A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. BMJ 313(7048), 29-33 (1996). (Pubitemid 26229887)
48. Korfage IJ, de Koning HJ, Essink-Bot ML. Response shift due to diagnosis and primary treatment of localized prostate cancer: a then-test and a vignette study. Qual. Life Res. 10, 1627-1634 (2007). (Pubitemid 350059904)
49. Ahmed S, Mayo NE, Wood-Dauphinee S, Hanley JA, Cohen SR. The structural equation modeling technique did not show a response shift, contrary to the results of the then test and the individualized approaches. J. Clin. Epidemiol. 58(11), 1125-1133 (2005). (Pubitemid 41441700)
50. Schmitt N. The use of analysis of covariance structures to assess b and g change. Multivariate Behavioural Research 17, 343-358 (1982).
51. Oort FJ. Using structural equation modeling to detect response shifts and true change. Qual. Life Res. 14(3), 587-598 (2005). (Pubitemid 40576848)
52. Andrykowski MA, Donovan KA, Jacobsen PB. Magnitude and correlates of response shift in fatigue ratings in women undergoing adjuvant therapy for breast cancer. J. Pain Symptom Manage. 37, 341-351 (2009).
53. Sprangers MAG, van Dam FSAM, Broersen J et al. Revealing response shift in longitudinal research on fatigue: the use of the then-test approach. Acta Oncol. 38, 709-718 (1999). (Pubitemid 29441433)
54. Schwartz CE, Feinberg RG, Jilinskaia E, Applegate JC. An evaluation of a psychosocial intervention for survivors of childhood cancer: paradoxical effects of response shift over time. Psycho-Oncology 8, 344-354 (1999). (Pubitemid 29417489)
55. Oort FJ, Visser MR, Sprangers MA. An application of structural equation modeling to detect response shifts and true change in quality of life data from cancer patients undergoing invasive surgery. Qual. Life Res. 14(3), 599-609 (2005). (Pubitemid 40576849)
56. Hagedoorn M, Sneeuw KC, Aaronson NK. Changes in physical functioning and quality of life in patients with cancer: response shift and relative evaluation of one's condition. J. Clin. Epidemiol. 55, 176-183 (2002). (Pubitemid 34051531)
57. Bernhard J, Lowy A, Maibach R, Hürny C; Swiss Group for Clinical Cancer Research (SAKK) and the Swiss Institute for Applied Cancer Research (SIAK). Response shift in the perception of health for utility evaluation. An explorative investigation. Eur. J. Cancer 37(14), 1729-1735 (2001). (Pubitemid 32817046)
58. Kvam AK, Wislff F, Fayers PM. Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma. Health Qual. Life Outcomes 3(8), 79 (2010).
59. Reeve BB. An opportunity to refine our understanding of "response shift" and to educate researchers on designing quality research studies: response to Ubel, Peeters, and Smith. Qual. Life Res. 19(4), 473-475 (2010).
60. Eisenhauer EA, Therasse P, Bogaerts J et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 45(2), 228-247 (2009).
61. Bonnetain F, Dahan L, Maillard E et al. Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma. Eur. J. Cancer 46(15), 2753-2762 (2010).
62. Hamidou Z, Dabakuyo TS, Mercier M et al. Time to deterioration in quality of life score as a modality of longitudinal analysis in patients with breast cancer. Presented at: 17th Annual Conference of the International Society for Quality of Life Research. London, UK, 27-30 October 2010.
63. WHO, WHOQOL measuring quality of life (1997) www.who.int/mental-health/ media/68.pdf
64. FDA Guidance Documents. Guidance for industry: clinical trial end points for the approval of cancer drugs and biologics www.fda.gov/downloads/Drugs/ GuidanceCompliance RegulatoryInformation/Guidances/ucm071590.pdf